Cargando…

Proteasome-associated deubiquitinases and cancer

Maintenance of protein homeostasis is a crucial process for the normal functioning of the cell. The regulated degradation of proteins is primarily facilitated by the ubiquitin proteasome system (UPS), a system of selective tagging of proteins with ubiquitin followed by proteasome-mediated proteolysi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mofers, Arjan, Pellegrini, Paola, Linder, Stig, D’Arcy, Pádraig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721125/ https://www.ncbi.nlm.nih.gov/pubmed/29134486 http://dx.doi.org/10.1007/s10555-017-9697-6

Ejemplares similares

Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15
por: Mofers, Arjan, et al.
Publicado: (2019)

Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570
por: Pellegrini, Paola, et al.
Publicado: (2020)

Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition
por: Mazurkiewicz, Magdalena, et al.
Publicado: (2017)

Elevation of Proteasomal Substrate Levels Sensitizes Cells to Apoptosis Induced by Inhibition of Proteasomal Deubiquitinases
por: Sun, Chao, et al.
Publicado: (2014)

Oxidative Stress Induced by the Deubiquitinase Inhibitor b-AP15 Is Associated with Mitochondrial Impairment
por: Zhang, Xiaonan, et al.
Publicado: (2019)

MYC is downregulated by a mitochondrial checkpoint mechanism
por: Zhang, Xiaonan, et al.
Publicado: (2017)

Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
por: Selvaraju, Karthik, et al.
Publicado: (2019)

Author Correction: Cytotoxic unsaturated electrophilic compounds commonly target the ubiquitin proteasome system
por: Selvaraju, Karthik, et al.
Publicado: (2019)

The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells
por: Wang, Xin, et al.
Publicado: (2016)

The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis
por: Corno, Cristina, et al.
Publicado: (2022)

Corrigendum: The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells
por: Wang, Xin, et al.
Publicado: (2016)

Sensitivity of Acute Myelocytic Leukemia Cells to the Dienone Compound VLX1570 Is Associated with Inhibition of the Ubiquitin-Proteasome System
por: Selvaraju, Karthik, et al.
Publicado: (2021)

Regulation of TRAIL-Receptor Expression by the Ubiquitin-Proteasome System
por: Sarhan, Dhifaf, et al.
Publicado: (2014)

A drug screening assay on cancer cells chronically adapted to acidosis
por: Pellegrini, Paola, et al.
Publicado: (2018)

Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases
por: Moon, Seonghyeon, et al.
Publicado: (2021)

Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors
por: Zhang, Xiaonan, et al.
Publicado: (2015)

Inhibition of 19S proteasome-associated deubiquitinases by metal-containing compounds
por: Liu, Ningning, et al.
Publicado: (2015)

Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents
por: Chen, Xin, et al.
Publicado: (2017)

Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer
por: Xia, Xiaohong, et al.
Publicado: (2018)

Atomic structure of the 26S proteasome lid reveals the mechanism of deubiquitinase inhibition
por: Dambacher, Corey M, et al.
Publicado: (2016)

Ubp6 deubiquitinase controls conformational dynamics and substrate degradation of the 26S proteasome
por: Bashore, Charlene, et al.
Publicado: (2015)

Deubiquitinase Ubp3 enhances the proteasomal degradation of key enzymes in sterol homeostasis
por: Lan, Qiuyan, et al.
Publicado: (2021)

Comprehensive Target Screening and Cellular Profiling of the Cancer-Active Compound b-AP15 Indicate Abrogation of Protein Homeostasis and Organelle Dysfunction as the Primary Mechanism of Action
por: Gubat, Johannes, et al.
Publicado: (2022)

Drug Development Targeting the Ubiquitin–Proteasome System (UPS) for the Treatment of Human Cancers
por: Zhang, Xiaonan, et al.
Publicado: (2020)

Deubiquitinase activity is required for the proteasomal degradation of misfolded cytosolic proteins upon heat-stress
por: Fang, Nancy N., et al.
Publicado: (2016)

The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma
por: Vdovin, Alexander, et al.
Publicado: (2022)

Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
por: Liao, Yuning, et al.
Publicado: (2017)

A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases
por: Liu, Ningning, et al.
Publicado: (2014)

Iron chelators target both proliferating and quiescent cancer cells
por: Fryknäs, Mårten, et al.
Publicado: (2016)

Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases
por: Zhao, Chong, et al.
Publicado: (2017)

Deubiquitinases in cancer
por: Wei, Rongbin, et al.
Publicado: (2015)

Oncogenic Functions of the Cancer-Testis Antigen SSX on the Proliferation, Survival, and Signaling Pathways of Cancer Cells
por: D’Arcy, Padraig, et al.
Publicado: (2014)

Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19
por: Clemente, Valentino, et al.
Publicado: (2020)

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
por: Liu, Ningning, et al.
Publicado: (2014)

Entropic stabilization of a deubiquitinase provides conformational plasticity and slow unfolding kinetics beneficial for functioning on the proteasome
por: Lee, Yun-Tzai Cloud, et al.
Publicado: (2017)

Deubiquitinases and cancer: A snapshot
por: Singh, Nishant, et al.
Publicado: (2016)

Deubiquitinases in Neurodegeneration
por: Bello, Abudu I., et al.
Publicado: (2022)

Synthesis and bio-properties of 4-piperidone containing compounds as curcumin mimics
por: Girgis, Adel S., et al.
Publicado: (2022)

Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
por: Rowinsky, Eric K., et al.
Publicado: (2020)

Inhibition of proteasomal deubiquitinases USP14 and UCHL5 overcomes tyrosine kinase inhibitor resistance in chronic myeloid leukaemia
por: Jiang, Liling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_joeukc76m7umstf8jpmb5u1k52